Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;16(3):127-135.
doi: 10.1097/CU9.0000000000000128. Epub 2022 Aug 31.

Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer

Affiliations

Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer

Essam A Shalaby et al. Curr Urol. 2022 Sep.

Abstract

Objectives: To assess the role of multiparametric magnetic resonance imaging (mp-MRI) in the diagnosis and staging of urinary bladder cancer (BC).

Materials and methods: Fifty patients diagnosed with bladder masses underwent mp-MRI study. The results of 3 image sets were analyzed and compared with the histopathological results as a reference standard: T2-weighted image (T2WI) plus dynamic contrast-enhanced (DCE), T2WI plus diffusion-weighted images (DWI), and mp-MRI, including T2WI plus DWI and DCE. The diagnostic accuracy of mp-MRI was evaluated using receiver operating characteristic curve analysis.

Results: The accuracy of T2WI plus DCE for detecting muscle invasion of BC was 79.5% with a fair agreement with histopathological examination (κ = 0.59); this percentage increased up to 88.6% using T2WI plus DWI, with good agreement with histopathological examination (κ = 0.74), whereas mp-MRI had the highest overall accuracy (95.4%) and excellent agreement with histopathological data (κ = 0.83). Multiparametric MRI can differentiate between low- and high-grade bladder tumors with a high sensitivity and specificity of 93.3% and 98.3%, respectively.

Conclusions: Multiparametric MRI is an acceptable method for the preoperative detection and accurate staging of BC, with reasonable accuracy in differentiating between low- and high-grade BC.

Keywords: Apparent diffusion coefficient; Bladder cancer; Diffusion-weighted imaging; Multiparametric magnetic resonance imaging; Transurethral resection of bladder tumor.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest has been declared by the authors.

Figures

Figure 1
Figure 1
ROC, sensitivity, and specificity of the ADC value in detecting muscle invasion in bladder cancer. ADC = apparent diffusion coefficient; ROC = receiver operating characteristic curve.
Figure 2
Figure 2
Box plots comparing measured ADC values and their corresponding pathological grades. ADC = apparent diffusion coefficient.
Figure 3
Figure 3
(A) Axial CT of the pelvis reveals a large bladder mass (red arrow). (B) Axial T2W MRI scan of the pelvis reveals a fungating intravesical mass with evidence of muscle layer and perivesical fat invasion (yellow arrows). (C) Axial diffusion-weighted image (b = 1000 s/mm2). (D) ADC map of the pelvis reveals a bladder mass infiltrating the anterior wall and perivesical fat. ADC value = 1 × 103 mm2/s. (E) Axial DCE. (F) Time-intensity curve showing an enhancing infiltrating bladder mass and evidence of wall infiltration (green arrow) and Type III curve “washout.” ADC = apparent diffusion coefficient; CT = computed tomography; DCE = dynamic contrast enhanced; MRI = magnetic resonance imaging; T2W = T2-weighted. b value measures the degree of diffusion weighting applied, thereby indicating the amplitude (G), time of applied gradients (δ) and duration between the paired gradients (△) and is calculated as: b = γ2 G2 δ2 (△−δ/3).
Figure 4
Figure 4
(A) Axial T2W MRI. (B) Coronal T2W. (C) Sagittal T2W MRI scans of the pelvis show diffuse wall thickening, a sessile mass lesion in the left lateral wall, and evidence of perivesical fat infiltration (red arrows). (D) Axial diffusion-weighted image (b = 1000 s/mm2) of the pelvis reveals bladder mass showing no restricted diffusion “facilitated” (yellow arrows). ADC value = 2.4 × 103 mm2/s. (E) Time-intensity curve showing a Type I curve “rising.” (F) Hematoxylin-eosin‐stained slide reveals follicular cystitis. ADC = apparent diffusion coefficient; MRI = magnetic resonance imaging; T2W = T2-weighted. b value measures the degree of diffusion weighting applied, thereby indicating the amplitude (G), time of applied gradients (δ) and duration between the paired gradients (△) and is calculated as: b = γ2 G2 δ2 (△−δ/3).
Figure 5
Figure 5
(A) Axial CT image of the pelvis shows a polypoidal mass lesion in the posterior wall. (B) Axial T2WI MRI of the pelvis reveals a polypoidal mass lesion with intact hypointense muscle layer (red arrow). (C) Axial diffusion-weighted image (b = 1000 s/mm2). (D) ADC map of the pelvis reveals a bladder mass with an intact muscle layer and positive inchworm sign (yellow arrows). ADC value = 1.7 × 103 mm2/s. (E) Sagittal DCE. (F) Time-intensity curve; shows early enhancing bladder mass (green arrow), no early bladder wall enhancement, and Type II curve “plateau.” ADC = apparent diffusion coefficient; CT = computed tomography; DCE = dynamic contrast enhanced; MRI = magnetic resonance imaging; T2WI = T2-weighted image. b value measures the degree of diffusion weighting applied, thereby indicating the amplitude (G), time of applied gradients (δ) and duration between the paired gradients (△) and is calculated as: b = γ2 G2 δ2 (△−δ/3).

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. - PubMed
    1. Adeloye D Harhay MO Ayepola OO, et al. . Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis. Int J Urol 2019;26(1):102–112. - PMC - PubMed
    1. Babjuk M Böhle A Burger M, et al. . EAU guidelines on non‐muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017;71(3):447–461. - PubMed
    1. Kulkarni GS Hakenberg OW Gschwend JE, et al. . An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 2010;57(1):60–70. - PubMed
    1. El-Barky E, Sebaey A, Eltabey M, Aboutaleb A, Hussein S, Kehinde EO. The importance of second-look transurethral resection for superficial bladder cancer. J Clin Urol 2015;8(5):299–305.

LinkOut - more resources